Risk of Recurrent CeAD After Pregnancy
Part of paid clinical trials in Salt Lake City, Utah.
- Sponsor
- University Hospital, Basel, Switzerland
- Study ID
- NCT06258109
- Status
- Recruiting
Conditions
- Cervical Artery Dissection
- Pregnancy Complications
Eligibility Criteria
- Sex
- FEMALE
- Age
- 18 Years - N/A
- Healthy Volunteers
- Not accepted
Study Details
Primary objective: To determine whether pregnancy increases the risk of recurrent CeAD and delayed stroke in women with prior CeAD based on long-term data. Methods: Multicentric, observational case-control study based on pooled individual patient data from several stroke centers. Primary endpoint: Primary composite outcome measure includes the following outcomes: (i) occurrence of recurrent CeAD, (ii) occurrence of ischemic or hemorrhagic stroke, (iii) death.
Key Dates
- Start date
- Jan 1, 2023
- Status verified
- Dec 2024
- Primary completion
- Dec 1, 2024
- Completion
- Jul 1, 2025
Study Design
- Enrollment
- 1,000 participants (estimated)
Arms
- Arm: Women with pregnancy after index CeADWomen who became pregnant at least once after first index CeAD
- Arm: Women without pregnancy after index CeADWomen who did not became pregnant after first index CeAD
Primary Outcome Measure
Number of participants with composite outcome measure - recurrent CeAD, ischemic stroke, hemorrhagic stroke and/or death [ Time Frame: From date of first CeAD until date of latest follow-up assessed up to 35 years ]
Central Contacts
- Stefan T Engelter, MD+41 61 326 41 05
- Sandro K Fischer+41 61 328 47 84
Locations (2)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| University of Utah | Salt Lake City | Utah | 84112 | - |
| University of Virginia | Charlottesville | Virginia | 22908 | - |
Find similar trials in Salt Lake City, UT
Related Studies
- IMPACT Study: IMProve Pregnancy in APS With Certolizumab TherapyPHASE2 · Recruiting · David Ware Branch · New York, New York
- Placental Imaging TechniquesRecruiting · Carilion Clinic · Roanoke, Virginia
- Defining the Basis of Fibromuscular Dysplasia (FMD)Recruiting · Icahn School of Medicine at Mount Sinai · New York, New York
- Boston Birth Cohort StudyRecruiting · Johns Hopkins Bloomberg School of Public Health · Boston, Massachusetts